Exagamglogene autotemcel (exa-cel), a CRISPR/Cas9 gene-edited cell therapy, eliminated vaso-occlusive crises in 97% of ...

Getting seminal first-person shooter Doom running on minimal or bizarre hardware is a sport among hackers, but the fact that Doom runs in fast, portable C makes it possible. What if Doom were instead ...

Pfizer is voluntarily withdrawing its sickle cell disease (SCD) therapy Oxbryta from all world markets after finding an "imbalance" in deaths in its clinical trials programme. It's a blow to the SCD ...

Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access scheme ...

Department of Medical-Diagnostic Sciences, University of Padua, Padua, Italy Correspondence to Dr D Corrado, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua Medical School, ...

Correspondence to Dr Jonathan A Drezner, Sports Medicine Center, University of Washington, Seattle, WA 98195, USA; jdrezner{at}uw.edu Objective To investigate the aetiology and incidence of sudden ...